HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SKB BIO

463.000

-11.400-2.40%

Volume:386.82K

Turnover:179.64M

Market Cap:110.66B

PE:-239.10

High:473.800

Open:465.200

Low:459.800

Close:474.400

52wk High:581.000

52wk Low:339.600

Shares:239.00M

HK Float Shares:177.00M

Volume Ratio:0.97

T/O Rate:0.22%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.936

ROE:2.92%

ROA:0.03%

PB:17.74

PE(LYR):-239.10

PS:45.39

Loading ...

Overview Company News Filings

Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 5.34% at Open, ASCO Oral Presentations and Multiple Phase III Successes Drive Momentum

SKB BIO Highlights Robust Sac-TMT Phase III and Lunbotinib Phase II Data Ahead of ASCO 2026

Bulletin Express

SKB BIO (06990) to Present Multiple Innovative Drug Research Findings at 2026 ASCO Annual Meeting

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Nda for Lunbotinib Fumarate Accepted for Review by Nmpa

THOMSON REUTERS

BRIEF-Kelun-Biotech's Sac-TMT + Pembrolizumab Improves Survival In Late-Stage China Trial

Sichuan Kelun-Biotech Biopharmaceutical: Sacituzumab Tirumotecan + Pembrolizumab Extended Pfs VS Pembrolizumab Alone in Phase 3 Lung Cancer Trial

THOMSON REUTERS

Sichuan Kelun-Biotech Biopharmaceutical-Safety Profile of Sac-TMT + Pembrolizumab Generally Manageable, Consistent With Safety Profile of Components

THOMSON REUTERS

Kelun, Merck's lung cancer combo improves survival in late-stage China trial

Kelun-Biotech says sac-TMT beats chemotherapy in Phase III first-line TNBC PFS

SKB BIO Shares Surge Over 5% on Positive Phase III Results for TROP2 ADC Developed with Merck

Stock Track | SKB BIO Soars 5.22% Intraday on Positive Phase III Trial Results and Regulatory Approval

Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 3.52% in Regular Trading, TROP2 ADC Phase III Trial Achieves Dual Primary Endpoints in Endometrial Cancer

A Look At Sichuan Kelun-Biotech Biopharmaceutical’s (SEHK:6990) Valuation After New Oncology Regulatory Milestones

Simply Wall St.

SKB BIO Shares Surge Over 5% in Morning Session on Merck's TROP2 ADC Therapy Phase 3 Success

Sichuan Kelun-Biotech Biopharmaceutical Receives NMPA Approval For IND Application For SKB118 (CR-001)

Sichuan Kelun-Biotech Wins China IND Nod for Cancer Therapy

MT Newswires Live

SKB BIO Receives NMPA Approval for Investigational New Drug Application of SKB118

SKB BIO Secures NMPA Green Light for PD-1/VEGF Bispecific Antibody SKB118; Crescent Biopharma Collaboration Advances Global Development

Bulletin Express

Kelun-Biotech says China regulator clears SKB118 clinical trial application

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Receives Nmpa Approval for Ind Application for Skb118 (Cr-001) for Advanced Solid Tumors

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/06990/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO","latestPrice":463,"timestamp":1789111176859,"preClose":474.4,"halted":0,"volume":386820,"delay":0,"changeRate":-0.024030354131534523,"floatShares":177000000,"shares":239000000,"eps":-1.9363984617857875,"marketStatus":"Trading","change":-11.4,"latestTime":"09-11 15:19:38","open":465.2,"high":473.8,"low":459.8,"amount":179644840,"amplitude":0.029511,"askPrice":463.6,"askSize":1200,"bidPrice":463,"bidSize":200,"shortable":3,"etf":0,"ttmEps":0.7576010113866278,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789114200000},"marketStatusCode":2,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":474.4,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"volumeRatio":0.974905,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":177000000,"roa":"0.03%","roe":"2.92%","lyrEps":-1.936398,"volumeRatio":0.974905,"shares":239000000,"dividePrice":0,"high":473.8,"amplitude":0.029511,"preClose":474.4,"low":459.8,"week52Low":339.6,"pbRate":"17.74","psRate":"45.39","week52High":581,"institutionHeld":0,"latestPrice":463,"committee":-0.714286,"eps":-1.9363984617857875,"divideRate":0,"volume":386820,"delay":0,"ttmEps":0.7576010113866278,"open":465.2,"prevYearClose":392.2,"prevWeekClose":489.4,"prevMonthClose":497.2,"prevQuarterClose":436.2,"fiveDayClose":489.4,"twentyDayClose":520.5,"sixtyDayClose":403.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2026-08-17","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786930200000,"name":null,"time":"","dateTimestamp":1786896000000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"06990","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post-Mkt","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"Post-Mkt","dateTimestamp":1723996800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4091,"buy":0.5909,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5909,"analysts":22,"updateTime":1786636800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2026-09-10","current":611.139628,"percent":0.978233,"low":-351.800852,"twenty":-235.638328,"median":-134.270923,"eighty":-51.131881,"high":737.230287,"avg":-122.764243,"sd":149.239469,"marketCap":113392970893},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-07","current":-120.930715,"twenty":-203.710245,"median":-131.985022,"eighty":-48.610423,"marketCap":95373061321},{"date":"2025-11-14","current":-137.099974,"twenty":-201.138492,"median":-131.729362,"eighty":-48.622244,"marketCap":108431475585},{"date":"2025-11-21","current":-125.836792,"twenty":-194.360264,"median":-130.233026,"eighty":-48.651606,"marketCap":99477134375},{"date":"2025-11-28","current":-134.139839,"twenty":-194.090443,"median":-131.64896,"eighty":-48.675637,"marketCap":106426076251},{"date":"2025-12-05","current":-134.965867,"twenty":-192.863217,"median":-131.473703,"eighty":-48.751223,"marketCap":107265545740},{"date":"2025-12-12","current":-128.449432,"twenty":-188.527876,"median":-130.526276,"eighty":-48.814858,"marketCap":102275366003},{"date":"2025-12-19","current":-122.479247,"twenty":-187.446049,"median":-129.499037,"eighty":-48.911385,"marketCap":97751558204},{"date":"2025-12-24","current":-122.098928,"twenty":-187.290368,"median":-128.758533,"eighty":-48.913338,"marketCap":97751558204},{"date":"2026-01-02","current":-116.223952,"twenty":-179.729041,"median":-128.478737,"eighty":-49.104524,"marketCap":93414299181},{"date":"2026-01-09","current":-137.872108,"twenty":-173.799059,"median":-128.508043,"eighty":-49.251224,"marketCap":111089795631},{"date":"2026-01-16","current":-136.67551,"twenty":-173.152374,"median":-129.252083,"eighty":-49.296233,"marketCap":110483512112},{"date":"2026-01-23","current":-124.044288,"twenty":-172.874196,"median":-128.511935,"eighty":-49.590244,"marketCap":100176692282},{"date":"2026-01-30","current":-119.398299,"twenty":-172.654145,"median":-128.43808,"eighty":-50.08289,"marketCap":96865451522},{"date":"2026-02-06","current":-121.3325,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"marketCap":98684302080},{"date":"2026-02-13","current":-119.328264,"twenty":-171.604872,"median":-127.229577,"eighty":-50.349599,"marketCap":97611646623},{"date":"2026-02-20","current":-118.929435,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"marketCap":97145274685},{"date":"2026-02-27","current":-109.393801,"twenty":-170.608939,"median":-126.362178,"eighty":-50.420375,"marketCap":90336244390},{"date":"2026-03-06","current":-109.941252,"twenty":-169.952459,"median":-125.237252,"eighty":-50.5225,"marketCap":90056421227},{"date":"2026-03-13","current":-111.874188,"twenty":-169.826622,"median":-125.028422,"eighty":-50.583009,"marketCap":92061820561},{"date":"2026-03-20","current":-118.784792,"twenty":-169.647858,"median":-124.510593,"eighty":-50.752344,"marketCap":97378460654},{"date":"2026-03-27","current":-246.717525,"twenty":-170.608939,"median":-124.791344,"eighty":-50.880899,"marketCap":106705913600},{"date":"2026-04-02","current":-270.1664,"twenty":-172.638036,"median":-125.053164,"eighty":-50.929189,"marketCap":117409151000},{"date":"2026-04-10","current":-262.507699,"twenty":-173.162671,"median":-125.237252,"eighty":-50.974222,"marketCap":114960698000},{"date":"2026-04-17","current":-276.768173,"twenty":-188.270393,"median":-126.362178,"eighty":-51.053793,"marketCap":121256720000},{"date":"2026-04-24","current":-263.25072,"twenty":-199.457552,"median":-126.777731,"eighty":-51.109685,"marketCap":115341038016},{"date":"2026-04-30","current":-249.758244,"twenty":-207.783795,"median":-127.598017,"eighty":-51.131881,"marketCap":109457493848},{"date":"2026-05-08","current":-237.123047,"twenty":-214.424086,"median":-128.140667,"eighty":-51.206724,"marketCap":104280765336},{"date":"2026-05-15","current":-230.895214,"twenty":-220.549694,"median":-128.478737,"eighty":-51.422215,"marketCap":101808994065},{"date":"2026-05-22","current":-251.35436,"twenty":-225.355554,"median":-129.00513,"eighty":-51.539533,"marketCap":110576786499},{"date":"2026-05-29","current":-244.039033,"twenty":-227.151092,"median":-129.499037,"eighty":-51.775379,"marketCap":107731917678},{"date":"2026-06-05","current":-207.501784,"twenty":-227.151092,"median":-130.526276,"eighty":-51.91711,"marketCap":91735360204},{"date":"2026-06-12","current":-219.148588,"twenty":-226.740676,"median":-131.473703,"eighty":-52.267792,"marketCap":96818814328},{"date":"2026-06-18","current":-218.939992,"twenty":-226.404961,"median":-131.824218,"eighty":-52.561632,"marketCap":96958725910},{"date":"2026-06-26","current":-221.178526,"twenty":-225.594566,"median":-132.326202,"eighty":-52.73121,"marketCap":97471735042},{"date":"2026-07-03","current":-263.841103,"twenty":-227.197711,"median":-132.771691,"eighty":-52.93717,"marketCap":116359798531},{"date":"2026-07-10","current":-273.42961,"twenty":-228.864297,"median":-133.50718,"eighty":-53.148078,"marketCap":120440552988},{"date":"2026-07-17","current":-263.005613,"twenty":-229.666754,"median":-134.182751,"eighty":-53.480935,"marketCap":116261258521},{"date":"2026-07-24","current":-277.867014,"twenty":-230.754675,"median":-134.677954,"eighty":-54.022455,"marketCap":122858320066},{"date":"2026-07-31","current":-261.04507,"twenty":-231.704791,"median":-134.965867,"eighty":-54.274788,"marketCap":115639796202},{"date":"2026-08-07","current":-290.535115,"twenty":-235.013451,"median":-135.70577,"eighty":-54.298503,"marketCap":128953431275},{"date":"2026-08-14","current":-279.9487,"twenty":-236.676246,"median":-136.101797,"eighty":-54.329175,"marketCap":124411975864},{"date":"2026-08-21","current":729.337059,"twenty":-236.676246,"median":-135.748112,"eighty":-53.902639,"marketCap":128594895322},{"date":"2026-08-28","current":697.321291,"twenty":-236.422847,"median":-135.694724,"eighty":-52.683151,"marketCap":122977832050},{"date":"2026-09-04","current":663.036146,"twenty":-235.974841,"median":-134.724854,"eighty":-51.598494,"marketCap":116978330428},{"date":"2026-09-10","current":641.84806,"twenty":-235.638328,"median":-134.270923,"eighty":-51.131881,"marketCap":113392970893}],"updateTime":1789111178617},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1183196023","title":"Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 5.34% at Open, ASCO Oral Presentations and Multiple Phase III Successes Drive Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1183196023","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183196023?lang=en_us&edition=fundamental","pubTime":"2026-05-22 09:24","pubTimestamp":1779413063,"startTime":"0","endTime":"0","summary":"On May 22, Kelun-Biotech Biopharmaceutical rose 5.34% at open, trading at 477.8 HKD/share, with trading volume of approximately 5.86 million HKD.On the news front, the company announced it will...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164172096","title":"SKB BIO Highlights Robust Sac-TMT Phase III and Lunbotinib Phase II Data Ahead of ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1164172096","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164172096?lang=en_us&edition=fundamental","pubTime":"2026-05-22 07:43","pubTimestamp":1779406990,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) will release results from three oncology programs at the American Society of Clinical Oncology (ASCO) Annual Meeting, 29 May–2 June 2026,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154215999","title":"SKB BIO (06990) to Present Multiple Innovative Drug Research Findings at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1154215999","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154215999?lang=en_us&edition=fundamental","pubTime":"2026-05-22 07:41","pubTimestamp":1779406889,"startTime":"0","endTime":"0","summary":"SKB BIO (06990) announced that the company will present multiple company-led clinical research results at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held from May 29...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","159992","06990","06978","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637368292","title":"Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Nda for Lunbotinib Fumarate Accepted for Review by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2637368292","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637368292?lang=en_us&edition=fundamental","pubTime":"2026-05-22 07:31","pubTimestamp":1779406263,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y148:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0196878994.USD","BK1161","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637350835","title":"BRIEF-Kelun-Biotech's Sac-TMT + Pembrolizumab Improves Survival In Late-Stage China Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2637350835","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637350835?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:03","pubTimestamp":1779397430,"startTime":"0","endTime":"0","summary":"BRIEF-Kelun-Biotech's Sac-TMT + Pembrolizumab Improves Survival In Late-Stage China TrialMay 22  - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 6990.HK:SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL-SAFETY PROFILE OF SAC-TMT + PEMBROLIZUMAB GENERALLY MANAGEABLE, CONSISTENT WITH SAFETY PROFILE OF COMPONENTSSICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL: SACITUZUMAB TIRUMOTECAN + PEMBROLIZUMAB EXTENDED PFS VERSUS PEMBROLIZUMAB ALONE IN PHASE 3 LUNG CANCER TRIALSICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL: OBJECTIVE RESPONSE RATE 70.2% WITH SAC-TMT PLUS PEMBROLIZUMAB VERSUS 42.0% WITH PEMBROLIZUMAB ALONEFurther company coverage: 6990.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nP8N3Z60BM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1035773651.USD","SG9999001176.USD","LU0234572021.USD","LU1974910355.USD","LU1291159041.SGD","LU1069347547.HKD","LU0965509010.AUD","LU0942090050.USD","LU0648001328.SGD","LU0203345920.USD","BK4516","LU1023059063.AUD","SG9999014542.SGD","LU1699723380.USD","BK4533","LU1116320901.HKD","SG9999014567.USD","06990","LU1037948541.HKD","LU1934455194.USD","LU2023250504.SGD","LU2023250843.SGD","LU0965508806.USD","LU2361044949.HKD","LU0265550359.USD","LU0266013472.USD","LU0289739699.SGD","SG9999014559.SGD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","LU0098860793.USD","LU0130517989.USD","LU1057294990.SGD","LU0965509283.SGD","BK4534","LU0208291251.USD","LU1066051225.USD","LU1061106388.HKD","LU1201861249.SGD","BK4559","LU1983299246.USD","LU1430594728.SGD","LU1162221912.USD","LU0965509101.SGD","BK1161","LU0477156953.USD","LU0432979614.USD","IE000M9KFDE8.USD","LU1929549753.HKD","LU2324357040.USD","LU2433249047.HKD","IE00BJJMRZ35.SGD","LU0861579265.USD","LU1934455277.USD","LU0058720904.USD","LU1923622614.USD","BK4588","LU0320765646.SGD","LU0985320562.USD","LU2357627491.SGD","LU2112291526.USD","LU1116320737.USD","SG9999014575.USD","LU2125909247.SGD","LU2125154778.USD","LU1934455863.HKD","SG9999002232.USD","LU1093756325.SGD","LU0006306889.USD","LU2106854487.HKD","BK4550","IE00BFTCPJ56.SGD","LU2360032135.SGD","LU1066051498.USD","LU1037948897.HKD","LU1066053197.SGD","LU1989771016.USD","IE00BLSP4239.USD","LU2468319806.SGD","LU0868494617.USD","IE0002141913.USD","IE00BSNM7G36.USD","LU0130102774.USD","BK4007","LU2361045086.USD","LU0238689110.USD","LU2491049909.HKD","LU1571399168.USD","LU1941712264.USD","LU1066051811.HKD","LU1941712348.USD","SG9999015358.SGD","LU2089984988.USD","LU0980610538.SGD","LU2491050071.SGD","IE00B1BXHZ80.USD","LU0196878994.USD","IE00BLSP4452.SGD","LU0211331839.USD","SG9999001176.SGD","LU1989772923.USD","LU1093756168.USD","LU1585245621.USD","LU2361044865.SGD","SG9999015341.SGD","IE0009355771.USD","IE00BN8TJ469.HKD","IE00B2B36J28.USD","SG9999001440.SGD","IE00BJT1NW94.SGD","LU1989772840.SGD","LU0203347892.USD","LU2461242641.AUD","IE00BBT3K403.USD","LU2125909593.SGD","LU0106261372.USD","LU2125154935.USD","BK4585","LU2491050154.USD","LU1917777945.USD","LU0320765489.SGD","LU0122379950.USD","LU0868494708.USD","LU0265550946.USD","SG9999013999.USD","LU0070302665.USD","LU0859254822.USD","SG9999002224.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637352029","title":"Sichuan Kelun-Biotech Biopharmaceutical: Sacituzumab Tirumotecan + Pembrolizumab Extended Pfs VS Pembrolizumab Alone in Phase 3 Lung Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2637352029","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637352029?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:03","pubTimestamp":1779397429,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nP8N3Z60BM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2491049909.HKD","SGXZ57979304.SGD","BK4585","LU2125154778.USD","SG9999015358.SGD","LU1989771016.USD","LU1983299246.USD","LU1116320737.USD","LU2125909593.SGD","SG9999002224.SGD","LU0203345920.USD","LU1023059063.AUD","LU1989772840.SGD","BK1161","06990","LU1201861249.SGD","LU1037948541.HKD","LU1941712264.USD","LU0238689110.USD","LU0196878994.USD","LU0234572021.USD","LU0122379950.USD","LU1571399168.USD","BK4007","SG9999001176.USD","LU1934455863.HKD","SG9999015341.SGD","LU1069347547.HKD","LU1929549753.HKD","LU1974910355.USD","LU0208291251.USD","BK4588","LU1066051498.USD","LU0320765646.SGD","BK4533","LU2125909247.SGD","IE000M9KFDE8.USD","IE00BSNM7G36.USD","IE0002141913.USD","LU0965509283.SGD","LU2023250504.SGD","LU0106261372.USD","LU2433249047.HKD","LU0130102774.USD","LU1934455194.USD","LU1989772923.USD","SG9999001176.SGD","IE00BJT1NW94.SGD","IE00BN8TJ469.HKD","LU2089984988.USD","LU1699723380.USD","LU1291159041.SGD","LU0432979614.USD","LU1430594728.SGD","LU0098860793.USD","SG9999014575.USD","LU0211331839.USD","SG9999014559.SGD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU1037948897.HKD","LU0942090050.USD","BK4550","LU1066053197.SGD","SG9999002232.USD","LU2491050071.SGD","LU0289739699.SGD","LU2361044865.SGD","LU0058720904.USD","LU0648001328.SGD","SG9999001440.SGD","SG9999013999.USD","LU0985320562.USD","LU0130517989.USD","LU0868494708.USD","LU1093756325.SGD","LU0477156953.USD","LU1162221912.USD","BK4559","LU2106854487.HKD","LU2361045086.USD","LU1066051811.HKD","LU0320765489.SGD","LU0861579265.USD","IE00BLSP4239.USD","LU0868494617.USD","LU1934455277.USD","LU1057294990.SGD","LU1066051225.USD","IE00B2B36J28.USD","LU0070302665.USD","LU2461242641.AUD","LU0203347892.USD","LU0859254822.USD","SG9999014567.USD","LU2491050154.USD","LU2023250843.SGD","LU1917777945.USD","BK4516","LU1093756168.USD","SG9999014542.SGD","LU0006306889.USD","IE00B1BXHZ80.USD","LU2360032135.SGD","LU0265550946.USD","LU1035773651.USD","LU0965509101.SGD","LU2125154935.USD","LU1585245621.USD","LU0266013472.USD","LU0265550359.USD","IE00B4R5TH58.HKD","IE00BBT3K403.USD","LU1923622614.USD","LU2324357040.USD","LU0965509010.AUD","LU1061106388.HKD","IE0009355771.USD","LU0980610538.SGD","LU2361044949.HKD","002422","LU1116320901.HKD","LU2357627491.SGD","LU2468319806.SGD","LU0965508806.USD","LU1941712348.USD","BK4534","IE00BJJMRZ35.SGD","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637352025","title":"Sichuan Kelun-Biotech Biopharmaceutical-Safety Profile of Sac-TMT + Pembrolizumab  Generally Manageable, Consistent With Safety Profile of Components","url":"https://stock-news.laohu8.com/highlight/detail?id=2637352025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637352025?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:03","pubTimestamp":1779397429,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nP8N3Z60BM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2112291526.USD","IE00B2B36J28.USD","LU0861579265.USD","LU0208291251.USD","LU1291159041.SGD","BK4007","IE0009355771.USD","SG9999014559.SGD","LU1929549753.HKD","LU0058720904.USD","LU2023250504.SGD","SG9999001176.SGD","LU1941712348.USD","BK4533","LU2461242641.AUD","LU2023250843.SGD","SG9999001176.USD","MRK","IE00BJT1NW94.SGD","IE0002141913.USD","SGXZ57979304.SGD","LU1061106388.HKD","LU1989772840.SGD","IE00BBT3K403.USD","LU0098860793.USD","LU1571399168.USD","LU0238689110.USD","LU0868494617.USD","LU1093756168.USD","LU0070302665.USD","SG9999002232.USD","LU2125154778.USD","LU2089984988.USD","LU0130102774.USD","LU0203345920.USD","LU0265550946.USD","LU0432979614.USD","LU1934455863.HKD","LU0265550359.USD","IE00BLSP4239.USD","LU1057294990.SGD","LU1983299246.USD","BK4534","IE00BJJMRZ35.SGD","LU1066051225.USD","LU0965509101.SGD","IE00BLSP4452.SGD","IE00B1BXHZ80.USD","LU1093756325.SGD","LU1917777945.USD","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU1941712264.USD","LU1035773651.USD","LU0965508806.USD","LU1430594728.SGD","LU1116320901.HKD","LU2491049909.HKD","LU0942090050.USD","LU2125154935.USD","LU0106261372.USD","LU1116320737.USD","SG9999014567.USD","LU2360032135.SGD","LU0196878994.USD","LU0985320562.USD","BK4516","SG9999014575.USD","SG9999015358.SGD","LU0320765646.SGD","LU0965509283.SGD","06990","LU2106854487.HKD","LU1923622614.USD","LU2125909593.SGD","BK4588","LU2324357040.USD","LU2361045086.USD","IE00B4R5TH58.HKD","BK4550","LU1934455194.USD","SG9999002224.SGD","IE00BN8TJ469.HKD","BK4559","LU0122379950.USD","LU0130517989.USD","LU1066053197.SGD","IE000M9KFDE8.USD","LU2491050071.SGD","LU1934455277.USD","LU1699723380.USD","LU1037948897.HKD","IE00BSNM7G36.USD","LU1037948541.HKD","LU0289739699.SGD","LU1585245621.USD","LU2357627491.SGD","SG9999015341.SGD","LU2468319806.SGD","LU1201861249.SGD","LU1989772923.USD","LU0868494708.USD","LU1069347547.HKD","LU0234572021.USD","SG9999014542.SGD","LU0203347892.USD","BK4585","LU0211331839.USD","LU2125909247.SGD","LU1023059063.AUD","LU0980610538.SGD","LU0320765489.SGD","LU1162221912.USD","BK1161","LU0477156953.USD","LU1066051498.USD","LU0006306889.USD","LU2433249047.HKD","LU1066051811.HKD","SG9999013999.USD","LU2361044865.SGD","LU0965509010.AUD","LU0266013472.USD","LU0648001328.SGD","LU2361044949.HKD","LU0859254822.USD","LU1974910355.USD","LU1989771016.USD","LU2491050154.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637520023","title":"Kelun, Merck's lung cancer combo improves survival in late-stage China trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2637520023","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637520023?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:02","pubTimestamp":1779397340,"startTime":"0","endTime":"0","summary":"Kelun, Merck's lung cancer combo improves survival in late-stage China trialMay 21 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical 6990.HK said on Thursday its experimental treatment combined with","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nL4N41Y24Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250843.SGD","LU2133065610.SGD","LU0310799852.SGD","LU1196032939.SGD","LU0211327993.USD","LU0432979614.USD","LU0823399737.USD","IE00B1BXHZ80.USD","LU1019632923.USD","LU0106261372.USD","LU1078025761.USD","LU0784384876.USD","LU0058720904.USD","LU0985320562.USD","LU1934453819.USD","LU2237443895.HKD","BK4585","LU0203345920.USD","IE00BLSP4452.SGD","LU1023059063.AUD","LU2293690249.USD","BK4534","LU0238689110.USD","LU2360032135.SGD","LU1355424745.HKD","LU0130102774.USD","LU1116320901.HKD","IE00BJT1NW94.SGD","SG9999002224.SGD","LU2355687059.USD","LU2324357040.USD","LU1989771016.USD","LU0965508806.USD","LU0211326839.USD","LU2114397693.USD","SG9999001176.USD","LU2125909247.SGD","LU0345777147.USD","LU2433249047.HKD","IE00B4R5TH58.HKD","SG9999015341.SGD","LU1162221912.USD","LU0997586515.USD","LU0047473722.SGD","LU1003077747.HKD","LU1941712348.USD","LU1093756325.SGD","LU2148510915.USD","LU1035773651.USD","LU0122379950.USD","LU1917777945.USD","LU1814569148.SGD","LU0006306889.USD","LU1929549753.HKD","BK4533","LU1267930813.SGD","LU2237443549.SGD","LU2361044949.HKD","LU2468319806.SGD","LU0976567544.SGD","LU0211326755.USD","LU0553294199.USD","LU0882574055.USD","LU1116320737.USD","LU1699723380.USD","LU0208291251.USD","LU0047473722.EUR","LU1934455277.USD","LU1170363599.USD","LU0158827948.USD","LU0648001328.SGD","LU0868494617.USD","LU1487256676.USD","LU1880407215.USD","LU1983299246.USD","SG9999001176.SGD","LU0128525689.USD","LU0957799991.USD","LU0949170426.SGD","LU1057294990.SGD","LU2023251221.USD","LU0887340254.USD","LU2237443622.USD","LU2491049909.HKD","LU0211328371.USD","LU0029864427.USD","LU0965509101.SGD","LU0920783379.SGD","SGXZ57979304.SGD","LU0171276677.USD","LU1430594728.SGD","LU0171293334.USD","LU0784385840.USD","LU0265550359.USD","LU0889566641.SGD","LU1037948897.HKD","LU0738911758.USD","LU2293690082.USD","SG9999013999.USD","LU0266013472.USD","SG9999001440.SGD","LU1037948541.HKD","LU2461242641.AUD","LU2491050154.USD","LU1066053197.SGD","LU0661504455.SGD","LU1989772840.SGD","SG9999014567.USD","LU1153584641.USD","LU1989772923.USD","LU0868494708.USD","SG9999014542.SGD","LU1066051225.USD","LU0792757196.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","LU1051770623.HKD","LU1481600234.SGD","IE0034235188.USD","LU0889565080.SGD","LU2106854487.HKD","LU2125909593.SGD","LU0857590862.USD","IE00BFTCPJ56.SGD","LU0526926950.USD","LU2237443465.HKD","LU0980610538.SGD","LU2089984988.USD","LU1015430645.USD","LU2091194634.USD","MRK","LU1496350502.SGD","LU2491050071.SGD","LU2357627491.SGD","LU0128525929.USD","LU0545039389.USD","LU1941712264.USD","LU2089284900.SGD","LU0949170772.SGD","LU1064130708.USD","BK0239","LU1093756168.USD","LU1273509221.SGD","LU1571399168.USD","LU1201861249.SGD","LU0289739699.SGD","LU1104425308.USD","LU2125154935.USD","LU0390134368.USD","LU1585245621.USD","LU1064927863.SGD","LU1261432733.SGD","IE0009355771.USD","BK4588","BK5011","LU1267930227.SGD","IE000M9KFDE8.USD","LU0203347892.USD","LU0114720955.EUR","LU0211331839.USD","LU1267930573.SGD","LU1934455863.HKD","LU0310800379.SGD","BK4550","LU0496365809.HKD","LU0823416689.USD","LU2279689827.SGD","LU1046234339.USD","LU2237443978.SGD","LU0861579265.USD","BK0060","LU2539964713.USD","LU0965509283.SGD","LU0052756011.USD","LU0965509010.AUD","LU0130517989.USD","LU0557290698.USD","LU1019634622.SGD","06990","IE00BSNM7G36.USD","LU0960981461.USD","03165","LU2361045086.USD","LU0477156953.USD","LU0575583348.USD","LU1880407132.USD","LU1301847155.USD","LU2089283258.USD","LU0320765646.SGD","LU1323610961.USD","IE00BN8TJ469.HKD","LU1923622614.USD","LU1496350171.SGD","IE0002141913.USD","IE00B3T34201.USD","LU0640478417.SGD","LU0920840948.USD","LU0784383803.USD","LU1066051498.USD","IE00B2B36J28.USD","LU0070302665.USD","LU1974910355.USD","LU1061106388.HKD","LU1153585028.USD","LU1003076772.USD","IE00BJJMRZ35.SGD","LU1069347547.HKD","BK1161","LU0964806797.USD","LU1267930490.SGD","LU1481599808.USD","SG9999014559.SGD","LU0234572021.USD","LU2023250504.SGD","LU0499090636.EUR","LU0345777659.USD","LU1064131003.USD","BK4559","LU2125154778.USD","LU0708994859.HKD","LU0196878994.USD","LU1979443071.USD","LU2361044865.SGD","LU0077335932.USD","LU0997586432.USD","LU0784385170.HKD","SG9999014575.USD","LU1291159041.SGD","BK4007","LU0757432116.USD","SG9999015358.SGD","BK4516","IE00BKPKM643.USD","LU0969580561.USD","LU0011850046.USD","LU0098860793.USD","SG9999002232.USD","LU2237443382.USD","LU0963555726.SGD","LU0972486137.USD","LU1934455194.USD","LU0265550946.USD","LU0310800965.SGD","LU1066051811.HKD","LU0859254822.USD","LU0942090050.USD","LU2108987350.USD","LU2112291526.USD","LU0320765489.SGD","LU0827474353.SGD","LU1084165304.USD","LU1119994496.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637133490","title":"Kelun-Biotech says sac-TMT beats chemotherapy in Phase III first-line TNBC PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2637133490","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637133490?lang=en_us&edition=fundamental","pubTime":"2026-05-21 22:05","pubTimestamp":1779372321,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical reported a prespecified interim analysis showing its Phase III OptiTROP-Breast03 study of sacituzumab tirumotecan met the primary endpoint of delaying disease worsening versus chemotherapy as a first-line treatment for unresectable locally recurrent or metastatic triple-negative breast cancer.Overall survival results have not been presented in a mature form yet, with a favorable trend seen so far.No new safety issues emerged, supporting continued development in the first-line setting.The readout positions the drug for potential label expansion beyond its existing China approval in later-line triple-negative breast cancer, with regulatory discussions planned with China’s drug regulator on next steps.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL7R5dDh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121194992","title":"SKB BIO Shares Surge Over 5% on Positive Phase III Results for TROP2 ADC Developed with Merck","url":"https://stock-news.laohu8.com/highlight/detail?id=1121194992","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121194992?lang=en_us&edition=fundamental","pubTime":"2026-05-21 11:05","pubTimestamp":1779332707,"startTime":"0","endTime":"0","summary":"SKB BIO (06990) rose more than 5%. As of press time, the stock was up 3.3%, trading at HK$451.4 with a turnover of HK$166 million. Recently, according to an announcement from SKB BIO, Merck announced...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU1571399168.USD","SG9999001176.SGD","LU0208291251.USD","SG9999001440.SGD","LU0648001328.SGD","LU0006306889.USD","SG9999013999.USD","LU1066051225.USD","LU2361044949.HKD","BK4516","BK4534","LU1934455863.HKD","LU1116320901.HKD","LU1201861249.SGD","LU0203347892.USD","LU1037948541.HKD","LU0980610538.SGD","LU2023250843.SGD","SG9999002224.SGD","IE00BN8TJ469.HKD","LU0130102774.USD","LU0320765646.SGD","IE00BSNM7G36.USD","BK4134","LU0942090050.USD","LU1941712264.USD","LU0965508806.USD","BK4080","LU1093756325.SGD","LU1917777945.USD","LU2357627491.SGD","LU1989772840.SGD","SGXZ57979304.SGD","BK4559","BK4588","LU2360032135.SGD","LU1162221912.USD","LU1989771016.USD","SG9999015341.SGD","LU1430594728.SGD","LU1983299246.USD","LU2491050071.SGD","LU0965509010.AUD","LU1923622614.USD","IE00BJT1NW94.SGD","LU1699723380.USD","SG9999001176.USD","LU1057294990.SGD","LU1934455194.USD","LU2491050154.USD","SG9999015358.SGD","LU0130517989.USD","LU0265550359.USD","LU2023250504.SGD","LU2125154935.USD","LU0203345920.USD","LU1989772923.USD","LU1974910355.USD","BK4007","LU0868494617.USD","LU0234572021.USD","IE00BLSP4239.USD","LU0965509101.SGD","SG9999014567.USD","IE000M9KFDE8.USD","LU2361045086.USD","SG9999014559.SGD","BK4533","IE0002141913.USD","IE00B1BXHZ80.USD","LU2361044865.SGD","LU0266013472.USD","LU1934455277.USD","LU2461242641.AUD","LU1023059063.AUD","LU0985320562.USD","SG9999014542.SGD","LU1941712348.USD","LU0098860793.USD","LU0477156953.USD","LU1066053197.SGD","LU0859254822.USD","LU1035773651.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU2491049909.HKD","LU0320765489.SGD","LU2089984988.USD","LU2112291526.USD","06990","LU2468319806.SGD","LU0238689110.USD","LU0868494708.USD","IE00BFTCPJ56.SGD","LU1585245621.USD","LU0070302665.USD","IE0009355771.USD","LU1291159041.SGD","LU1929549753.HKD","LU1037948897.HKD","IE00B2B36J28.USD","LU0432979614.USD","BK1161","MRK","LU0861579265.USD","LU0106261372.USD","LU0058720904.USD","BK4585","IE00B4R5TH58.HKD","LU0965509283.SGD","IE00BBT3K403.USD","LU0122379950.USD","LU1066051811.HKD","LU2433249047.HKD","IE00BLSP4452.SGD","LU1066051498.USD","LU0289739699.SGD","SG9999002232.USD","BK4550","LU2125909247.SGD","BK4231","LU0265550946.USD","LU0211331839.USD","LU2125154778.USD","LU1061106388.HKD","LU1116320737.USD","LU0196878994.USD","SG9999014575.USD","LU2106854487.HKD","LU1069347547.HKD","LU2125909593.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133296679","title":"Stock Track | SKB BIO Soars 5.22% Intraday on Positive Phase III Trial Results and Regulatory Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1133296679","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133296679?lang=en_us&edition=fundamental","pubTime":"2026-05-21 09:54","pubTimestamp":1779328497,"startTime":"0","endTime":"0","summary":"SKB BIO's stock surged 5.22% during intraday trading on Thursday, driven by positive clinical developments and regulatory progress.The rally was fueled by Merck's announcement that sacituzumab...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107878773","title":"Movement Alert｜Kelun-Biotech Biopharmaceutical Rises 3.52% in Regular Trading, TROP2 ADC Phase III Trial Achieves Dual Primary Endpoints in Endometrial Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1107878773","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107878773?lang=en_us&edition=fundamental","pubTime":"2026-05-21 09:52","pubTimestamp":1779328366,"startTime":"0","endTime":"0","summary":"On May 21, Kelun-Biotech Biopharmaceutical rose 3.52% in regular trading, trading at 454.6 HKD/share, with trading volume of approximately 51.11 million HKD. The rally was driven by continued...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636899669","title":"A Look At Sichuan Kelun-Biotech Biopharmaceutical’s (SEHK:6990) Valuation After New Oncology Regulatory Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2636899669","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636899669?lang=en_us&edition=fundamental","pubTime":"2026-05-20 08:40","pubTimestamp":1779237629,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) is back in focus after fresh oncology pipeline news, including priority review for sacituzumab tirumotecan in lung cancer and clinical trial approval for bispecific antibody SKB118 in advanced solid tumors.\nSee our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical.\nThese oncology updates come after a mixed stretch for the stock. A 1-day share price return of 1.27% lifted the HK$429.6 quote, but the 30-day share price return is down...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/a-look-at-sichuan-kelun-biotech-biopharmaceuticals-sehk6990","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/a-look-at-sichuan-kelun-biotech-biopharmaceuticals-sehk6990","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","BK4585","BK4588","06990","BK1161","XBI","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145380915","title":"SKB BIO Shares Surge Over 5% in Morning Session on Merck's TROP2 ADC Therapy Phase 3 Success","url":"https://stock-news.laohu8.com/highlight/detail?id=1145380915","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145380915?lang=en_us&edition=fundamental","pubTime":"2026-05-19 09:41","pubTimestamp":1779154861,"startTime":"0","endTime":"0","summary":"SKB BIO (06990) rose more than 5% in morning trading. At the time of writing, the stock was up 4.71% to HK$444.2, with a turnover of HK$38.44 million. The move follows an announcement from Merck that...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1069347547.HKD","SG9999015358.SGD","LU0477156953.USD","BK4080","LU1989771016.USD","SGXZ57979304.SGD","LU0980610538.SGD","LU0965509010.AUD","LU2112291526.USD","LU0265550946.USD","LU1291159041.SGD","SG9999001176.USD","IE00B2B36J28.USD","SG9999002224.SGD","LU2324357040.USD","LU0965509101.SGD","LU1989772840.SGD","LU2106854487.HKD","LU0130517989.USD","LU0208291251.USD","IE00BLSP4239.USD","LU2125154778.USD","LU0058720904.USD","LU1989772923.USD","LU0070302665.USD","LU2023250504.SGD","LU0130102774.USD","BK4585","LU0861579265.USD","LU0106261372.USD","BK4534","LU1983299246.USD","LU2357627491.SGD","LU2361045086.USD","BK4588","LU0985320562.USD","LU1093756168.USD","LU1116320901.HKD","LU0234572021.USD","IE00BSNM7G36.USD","LU1201861249.SGD","LU2491050071.SGD","LU2433249047.HKD","LU0868494708.USD","LU1585245621.USD","LU2361044949.HKD","LU1934455863.HKD","LU1037948897.HKD","BK4516","LU1066051498.USD","LU1941712348.USD","LU1066051225.USD","SG9999014567.USD","IE0009355771.USD","IE0002141913.USD","LU2023250843.SGD","LU0098860793.USD","LU0122379950.USD","LU0965509283.SGD","BK1161","LU1057294990.SGD","LU0006306889.USD","LU1037948541.HKD","LU0265550359.USD","LU0320765646.SGD","LU0289739699.SGD","LU0859254822.USD","LU2468319806.SGD","IE00BN8TJ469.HKD","IE00BJT1NW94.SGD","LU2125909247.SGD","LU0942090050.USD","LU1061106388.HKD","LU2125154935.USD","LU0196878994.USD","LU2491049909.HKD","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU0238689110.USD","SG9999001176.SGD","SG9999013999.USD","LU1116320737.USD","LU1934455277.USD","SG9999014559.SGD","LU1699723380.USD","LU1929549753.HKD","IE00BLSP4452.SGD","LU0432979614.USD","LU1923622614.USD","LU1162221912.USD","LU1023059063.AUD","LU1093756325.SGD","LU1066051811.HKD","06990","LU1941712264.USD","LU0211331839.USD","BK4559","LU0320765489.SGD","IE00BBT3K403.USD","BK4007","LU1066053197.SGD","LU0648001328.SGD","BK4533","BK4231","IE00BJJMRZ35.SGD","LU0868494617.USD","IE00B1BXHZ80.USD","LU2125909593.SGD","SG9999002232.USD","LU0203345920.USD","SG9999015341.SGD","SG9999014542.SGD","BK4550","LU1430594728.SGD","LU2461242641.AUD","LU1917777945.USD","LU0266013472.USD","LU1571399168.USD","LU1934455194.USD","LU2491050154.USD","LU1974910355.USD","LU2360032135.SGD","LU0203347892.USD","LU2361044865.SGD","LU1035773651.USD","SG9999014575.USD","IE000M9KFDE8.USD","LU2089984988.USD","IE00B4R5TH58.HKD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635189272","title":"Sichuan Kelun-Biotech Biopharmaceutical Receives NMPA Approval For IND Application For SKB118 (CR-001)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635189272","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635189272?lang=en_us&edition=fundamental","pubTime":"2026-05-13 14:03","pubTimestamp":1778652206,"startTime":"0","endTime":"0","summary":"May 13 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd <6990.HK>::*RECEIVES NMPA APPROVAL FOR IND APPLICATION FOR SKB118 (CR-001) FOR ADVANCED SOLID TUMORS*Further company coverage: 6990.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nRSDbtT8rv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK1161","BK0239","LU1064130708.USD","LU2148510915.USD","LU1979443071.USD","LU0196878994.USD","LU1934453819.USD","LU1064131003.USD","002422","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635227068","title":"Sichuan Kelun-Biotech Wins China IND Nod for Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2635227068","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635227068?lang=en_us&edition=fundamental","pubTime":"2026-05-13 09:57","pubTimestamp":1778637426,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical  received approval from China's National Medical Products Administration for the investigational new drug application of SKB118, according to a Wednesday Hong Kong bourse filing.The company said the PD-1/VEGF bispecific antibody is intended for the treatment of advanced solid tumors.The approval clears the company to begin clinical trials for the drug candidate in China, the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4581","IND","BK4588","BK1161","06990","XBI","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158310498","title":"SKB BIO Receives NMPA Approval for Investigational New Drug Application of SKB118","url":"https://stock-news.laohu8.com/highlight/detail?id=1158310498","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158310498?lang=en_us&edition=fundamental","pubTime":"2026-05-13 08:04","pubTimestamp":1778630686,"startTime":"0","endTime":"0","summary":"SKB BIO (06990) has announced that it has received a clinical trial notification from the Center for Drug Evaluation of the National Medical Products Administration. The notification grants approval...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162503034","title":"SKB BIO Secures NMPA Green Light for PD-1/VEGF Bispecific Antibody SKB118; Crescent Biopharma Collaboration Advances Global Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1162503034","media":"Bulletin Express","labels":["corporation","productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162503034?lang=en_us&edition=fundamental","pubTime":"2026-05-13 07:43","pubTimestamp":1778629386,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO; 06990) has obtained Investigational New Drug (IND) approval from China’s National Medical Products Administration (NMPA) for SKB118...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635922949","title":"Kelun-Biotech says China regulator clears SKB118 clinical trial application","url":"https://stock-news.laohu8.com/highlight/detail?id=2635922949","media":"Reuters","labels":["executive","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635922949?lang=en_us&edition=fundamental","pubTime":"2026-05-13 07:32","pubTimestamp":1778628733,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical received China NMPA clearance for an IND to start clinical trials of PD-1xVEGF bispecific antibody SKB118  in advanced solid tumors.Crescent Biopharma granted Kelun-Biotech exclusive rights in Greater China to develop, manufacture, and commercialize SKB118 under a strategic cooperation reached in December 2025.Crescent previously secured US FDA IND clearance in January 2026 to launch global Phase 1/2 ASCEND study in locally advanced or metastatic solid tumors, with planned enrollment of 290 patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Servic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL5rThZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934453819.USD","LU1064131003.USD","BK0060","BK0239","06990","LU1979443071.USD","LU2148510915.USD","BK1161","002422","LU0196878994.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635229126","title":"Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Receives Nmpa Approval for Ind Application for Skb118 (Cr-001) for Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2635229126","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635229126?lang=en_us&edition=fundamental","pubTime":"2026-05-13 07:32","pubTimestamp":1778628724,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P1KZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}